Electrophysiologic studies were performed in 15 patients with syncope and/or cardiac arrest who had the long QT syndrome and 11 control subjects who had normal QT invervals. The syndrome was familial in five patients and idiopathic in 10. All patients had a prolonged QT (546 68 msec, mean ± SD) and corrected QT (550 ± 51 msec). Incremental atrial pacing at cycle lengths of 600 to 400 msec resulted in shortening of the QT interval, but there was no significant difference in the magnitude or percent of shortening of the QT interval between patients with the long QT syndrome and control subjects. Intravenous propranolol did not influence the QT interval measured at fixed atrialpaced cycle lengths in patients with either the familial or idiopathic form of the syndrome. Programmed right and left ventricular stimulation with up to three extrastimuli before and during isoproterenol infusion did not induce sustained ventricular tachycardia or ventricular fibrillation in any of the patients. However, rapid polymorphic nonsustained ventricular tachycardia was induced in six of the 15 patients (40%). Neither the inducibility of nonsustained ventricular tachycardia nor the results of electropharmacologic testing with f-blockers proved to be of any prognostic value during the mean follow-up period of 28 ± 17 months. Electrophysiologic studies are of limited value in the diagnosis and treatment of patients with the long QT syndrome.
THE ASSOCIATION of QT interval prolongation, syncope, and sudden death is known as the long QT syndrome (LQTS). 1-8 The syndrome may be familial, with or without congenital deafness, or idiopathic. The diagnosis is based on the electrocardiographic finding of a prolonged QT interval with or without T wave abnormalities or T wave alternans.9 However, the diagnosis of LQTS may prove difficult in some patients because of spontaneous variability of the QT interval. Some investigators have reported that abnormal prolongation of the QT interval during exercise may distinguish patients with LQTS from normal individuals. 4 8 In addition, others have suggested the use of provocative tests such as isoproterenol infusion'0 and the Valsalva maneuver"' for diagnosis. The change in QT interval in response to atrial pacing has never been assessed as a diagnostic test for these patients.
The mechanism of syncope and sudden death in patients with LQTS has been documented to be poly-morphous ventricular tachycardia or ventricular fibrillation,2 8 and the mortality in untreated patients has been reported to be as high as 78%.4 8 Little data are available with regard to the value of programmed ventricular stimulation in patients with the LQTS. Furthermore, while many clinical studies have substantiated the beneficial clinical response to fl-blockers in those with LQTS, the mechanism of this beneficial effect is still obscure.
The purpose of this study was to assess (1) the results of an aggressive ventricular stimulation protocol in patients with LQTS, (2) the clinical significance of induced ventricular tachycardia, (3) the value of atrial pacing in the diagnosis of the LQTS, and (4) the effects of short-term fl-blockade on the QT interval at fixed rates of atrial pacing.
Materials and methods
Patients. The study population consisted of 15 patients with LQTS and 11 control subjects evaluated at the University of California, San Francisco, and Stanford Medical Centers from January 1977 to July 1983. Excluded from this study were patients with prolonged QT intervals and ventricular tachycardia resulting from drug therapy or electrolyte abnormalities.
The clinical characteristics of the patients are outlined in table 1. Their mean age ( + SD) was 32 + 13 years. The syndrome was familial in five and idiopathic in 10. Of the five patients with the familial syndrome, two (patients 10 and 11) belonged to the same family. Fourteen of the 15 patients had a history of syncope and 10 had a history of cardiac arrest. Ventricular tachycardia and/or fibrillation was documented in all but one patient. This patient (No. 5) had recurrent syncope and a long QT interval with frequent ventricular premature complexes on multiple 24 hr Holter recordings. Based on history, results of physical examination, electrocardiograms, chest x-rays, twodimensional echocardiograms, and results of cardiac catheterization with coronary angiography (five patients), it was determined that 12 patients had no demonstrable structural heart disease, while three patients had mitral valve prolapse.
Previous medical therapy included that with /3-blockers alone (eight patients) or in combination with diphenylhydantoin (four patients). Patient 11 had undergone left stellate ganglion ablation via the supraclavicular approach (histologically documented) 4 years before the electrophysiologic stimulation study after failure to respond to full-dose ,3-blockers. Five patients (Nos. 2, 4, 5, 7, and 12) had received type I antiarrhythmic drugs in the past (before the diagnosis of LQTS was made); all had recurrent symptoms and QT prolongation after type I antiarrhythmic drug therapy was discontinued.
All patients demonstrated prolongation of the QT interval (mean + SD = 546 + 45 msec). In 12 patients the interval was always abnormally prolonged. Three patients (Nos. 5, 10, and 15) had normal or borderline prolonged resting QT intervals but had episodic QT prolongation that was observed spontaneously as well as in response to emotional stress (patients 5 and 10) or exercise (patient 15). QT prolongation in these patients always occurred before documented episodes of torsade de pointes.
Eleven subjects undergoing a diagnostic electrophysiologic study for supraventricular tachycardia served as control subjects for the atrial pacing studies; none had organic heart disease or history of dizziness, syncope, cardiac arrest, or documented ventricular arrhythmias. Five were men and six women, and their ages ranged from 17 to 63 years (mean 41 + 15). The mean QT interval was 375 + 28 msec (range 330 to 410) and mean corrected QT (QTc) interval was 417 + 20 msec (range 380 to 440).
For the purpose of this study the upper limits of normal for the QT interval were determined with the frequency distribution table of Simonson et al. ' 2The QTc was obtained by dividing the measured QT interval by the square root of the preceding R-R interval during regular sinus rhythm (Bazett's formula); the upper limit of normal for QTc was defined as 0.45 sec."3 Electrophysiologic stimulation protocol. Patients were studied in the unsedated and postabsorptive state after informed consent was obtained. All antiarrhythmic drugs were discontinued for at least five half-lives before testing. Two or three quadripolar electrode catheters were inserted percutaneously into a femoral vein and positioned across the tricuspid valve, against the high lateral right atrium, and the right ventricular apex. In patients who underwent left ventricular stimulation, a bipolar electrode catheter was inserted percutaneously into a femoral artery and positioned against the left ventricular apex.
Electrocardiographic leads V,, I, and Ill, and the intracardiac recordings from the high right atrium, His bundle region, and right ventricular apex were displayed on an Electronics for Medicine VR-12 oscilloscope and recorded simultaneously at a paper speed of 50 or 100 mm/sec. Atrial and ventricular stimulation were performed with a programmable digital stimulator (Bloom, Inc.; Narberth, PA). The stimuli were 2 msec in duration with current strength either twice diastolic threshold (patients I to 13) or 5 mA in intensity (patients 14 and 15).
The QT interval was recorded during sinus rhythm and at the end of 30 sec of high right atrial pacing at cycle lengths of 600, 500, and 400 msec. These paced cycle lengths were associated with 1:1 atrioventricular conduction in the 11 patients with LQTS and in the 11 control subjects. The QT interval was measured from the earliest onset of the QRS deflection in any of the three electrocardiographic leads to the end of the T wave. During atrial pacing, only the last paced complex was used to measure the QT interval to avoid interruption of the T wave by the next pacing stimulus. All patients underwent both right ventricular overdrive pacing at cycle lengths of 500 to 270 msec and programmed ventricular stimulation with three extrastimuli to the right ventricu-CIRCULATION lar apex at two to three different drive cycle lengths. In the last nine patients studied a similar stimulation protocol was used at both the right ventricular outflow tract and the left ventricle before and after isoproterenol. Isoproterenol was infused at a dose titrated to maintain a heart rate of 120/min. The full protocol was completed with triple ventricular extrastimuli-even if nonsustained ventricula'r tachycardia was induced by single or double extrastimuli. Marked variability in the number of ventricular extrastimuli were observed in those with induced nonsustained ventricular tachycardia.
The short-term effects of fl-blockade were assessed in seven patients after the infusion of 0.2 mg/kg propranolol at a rate of 1 mg/min. One-to-one atrioventricular conduction to a paced atrial cycle length of 400 msec allowed for comparison of changes in QT interval at fixed atrial cycle lengths in five of the seven patients.
Sustained ventricular tachycardia was defined as that lasting at least 30 sec or requiring direct-current countershock for termination. Nonsustained ventricular tachycardia was defined as that 6 beats to 30 sec in duration. Ventricular tachycardia was defined as polymorphic if QRS complexes of two or more different morphologies were present. Polymorphic ventricular tachycardia was diagnosed as torsade de pointes if it met the following criteria14: (1) paroxysms of ventricular tachycardia with irregular rhythm at an average rate of 150 to 250 beats/min and (2) progressive changes in the amplitude and polarity of QRS complexes such that QRS complexes appeared to be twisting around the isoelectric baseline.
All patients were followed by one of the authors or the referring physicians at intervals of 3 to 6 months. Patients underwent left cervicothoracic sympathectomy (LCTS) if they had symptomiis refractory to full-dose /3-blockade (six patients). In two patients (patients 10 and 13) LCTS was performed after their first episode of cardiac arrest before an adequate trial with ,3B blockers. The decision to perform cardiac sympathectomy was made on the clinical grounds in each case independent of the results of the clectrophysiologic testing. LCTS was performed via the supraclavicular approach in all patients and included resectioni of the left stellate ganglion and the first three to four thoracic sympathetic ganglia (histologically documented).
Values were expressed as mean + 1 SD. The two-tailed t test for paired data was used to compare QT values at different paced cycle lengths in the same patients before and after administration of propranolol. To compare pacing-induced QT changes between control subjects and patients with LQTS, two-tailed t test for unpaired data was used.
Results
Effect of atrial pacing on QT interval. The change in QT interval in response to incremental atrial pacing was assessed in 11 patients with LQTS and in 11 control subjects (table 2) .
In all patients with LQTS the mean QT was significantly shorter during atrial pacing at a cycle length 600 msec than at the spontaneous heart rate. The QT interval showed significant additional shortening when atrial paced cycle length was shortened to 500 and 400 msec, respectively.
The control subjects also demonstrated a progressive shortening of the QT interval during incremental atrial pacing.
The mean difference in the QT interval at atrial paced cycle lengths of 600 and 500 msec was -6.6% in patients with LQTS and -6.0% in the control subjects (NS). The corresponding values of the mean difference in the QT values at paced cycle lengths of 500 and 400 msec were -8.1% and -6.6%, respectively (NS). The absolute magnitude and percentage change in the QT interval induced by incremental atrial pacing were similar in patients with LQTS and control subjects.
Effects of propranolol on QT interval. The effects of intravenous propranolol on the QT in five patients with LQTS are shown in table 3. During sinus rhythm propranolol caused slowing of the heart rate and significant lengthening of the QT interval in all patients. However, there was no significant difference in the QTc interval before and after administration of propranolol (mean QTc before = 504 + 41 msec, mean QTc after = 483 ± 44 msec; p > .3).
During atrial pacing at identical cycle lengths, no significant change in the mean QT was seen before or after /-blockade. There was also no significant difference in the response of the QT to propranolol in patients with familial (patients 10 and 11) and those with idiopathic LQTS (patients 9, 12, and 15).
Results of programmed ventricular stimulation. Programmed ventricular stimulation induced nonsustained ventricular tachycardia in six of the 15 patients (40%), but sustained ventricular tachycardia or fibrillation was not induced in any of the patients. Nonsustained ventricular tachycardia was induced by three right ventricular extrastimuli in three patients, by a single extrastimulus in one, and by overdrive pacing in one. Left ventricular stimulation with three extrastimuli induced nonsustained ventricular tachycardia in one patient. While the initiation of nonsustained ventricular tachycardia was reproducible, both the number and form of the QRS complexes, as well as the method of induction, varied widely.
The QRS complexes during induced ventricular tachycardia were polymorphic in all patients (see figure 2). The mean duration of the tachycardia was 30 ± 21 complexes (range 7 to 65), and the mean cycle length was 188 + 30 msec (160 to 240). Episodes terminated spontaneously and were not accompanied by symptoms except in one patient who experienced dizziness during a 13 sec episode of polymorphic ventricular tachycardia.
The induced episodes of polymorphic ventricular tachycardia appeared to differ from the spontaneous ones in both rate and contour (figures 1 and 2). The rate of induced ventricular tachycardia (range 250 to 370/ min) was faster than that of the spontaneous episodes (150 to 250/min). None of the induced paroxysms met the criteria for torsade de pointes. Sustained ventricular tachycardia or fibrillation was never induced.
In comparing patients with and without inducible ventricular tachycardia, there was no significant difference with respect to mean age, sex ratio, the type of LQTS, history of cardiac arrest, presence of mitral valve prolapse, or the effective refractory period of the ventricle (VERP).
The VERP determined at a ventricular paced cycle length of 500 msec ranged from 200 to 430 msec (mean = 269 + 68). In three patients the VERP was markedly prolonged at 360, 400, and 430 msec; none of the three had inducible ventricular tachycardia. In nine patients the VERP was measured at two or more sites (table 4 ). The VERP did not vary by more than 30 msec between ventricular sites in any of the patients. lTreatment and follow-up (table 5) . Of six patients with inducible polymorphic ventricular tachycardia, intravenous propranolol suppressed the induction of ventricular tachycardia in two patients; both were treated with maximally tolerated doses of /3-blockers. One of them (patient 7) underwent left cervicothoracic sympa- Sinus rhythm is present at a rate of 63/min and QT interval is 460 msec. The two lower rhythm strips (B and C) are continuous and show a self-terminating episode of torsade de pointes. Note that QT is markedly prolonged at 620 to 680 msec and T wave shows electrical alternans. thectomy 6 months later because of the recurrence of syncope and has been asymptomatic since then. However, because of the presence of frequent ventricular ectopics on numerous 24 hr Holter recordings, this patient was started on /3-blocker therapy. The other patient (patient 15) has been asymptomatic during a follow-up of 7 months. Among four patients in whom propranolol was ineffective over the short term for the suppression of induced ventricular tachycardia, one (patient 5) was treated with a /-blocker and three underwent LCTS because of a poor response to /3blockers (patient 6 and 9) or a history of cardiac arrest (patient 10). Over a mean follow-up period of 31 ± 7 months, none had a recurrence of cardiac arrest, but two (patients 5 and 9) had recurrent syncope. The control of symptoms required additional therapy with diphenylhydantoin in patient 5 and long-term atrial pacing in combination with /3-blockers in patient 9.
Of nine patients with noninducible ventricular tachycardia, the initial treatment consisted of maximally tolerated doses of /3-blocker alone in two (patients 2 and 1 1) and in combination with 300 mg diphenylhydantoin in three (patients 4, 8, and 12). Three patients underwent LCTS because of either recurrent symptoms on full-dose /8-blockade (patients 1 and 3) or because of an episode cardiac arrest while on no medication (patient 13). One patient did not receive Vol. 71, No. 1, January 1985 any treatment at the discretion of the referring physician. After sympathectomy, two patients were discharged on no medication but one (patient 13) was continued on propranolol at the discretion of the attending physician. Over a mean follow-up period of 27 ± 18 months, four patients (Nos. 1, 2, 1 1, and 13) suffered cardiac arrest, which proved fatal in two of them (patients 1 and 2). At the time of cardiac arrest, all four were taking maximally tolerated doses of /blockers and three of the four had previously undergone either left stellectomy (patient 1 1) or LCTS (patients I and 13). Patients 1 and 11 took /3-blockers because of recurrent syncope that occurred 6 and 20 months before the cardiac arrest. In the two survivors of cardiac arrest, the control of symptoms required high thoracic sympathectomy up to the first four thoracic ganglia and long-term atrial overdrive pacing in one (patient 1 1) and implantation of an automatic internal defibrillator in the other (patient 13).
Discussion
Frequency of ventricular tachycardia induction. Previously reported studies have described a low incidence of ventricular tachycardia inducibility in patients with LQTS.'`1 6 F RY Ao FIGURE 2. Spontaneous and induced ventricular tachycardias in a patient with LQTS. A, The continuous rhythm strips show a sustained espisode of spontaneous ventricular tachycardia at a rate of 150 to 160/min. Note that there is a progressive change in the polarity and morphology of the QRS complexes. The tachycardia was accompanied by loss of consciousness and required direct-current countershock (arrow). B, Induction of nonsustained ventricular tachycardia from the right ventricular apex with use of three extrastimuli. As compared with the spontaneous tachycardia, the tachycardia rate is faster (300/min), and the QRS complexes appear to be grossly different in morphology. The surface electrocardiographic leads V,. 1 260  260  240  8  500  300  280  9  500  240  250  240  10  500  250  240  1 1  500  230  240  210  12  500  250  270  230  13  600  290  300  14  600  400  380  15  500  220  230 LVA left ventricular apex; PCL = paced cycle length; RVA right ventricular apex; RVOT = right ventricular outflow tract. tients with the LQTS, even when an aggressive stimulation protocol is used.
The significance of the rapid, polymorphic, nonsustained ventricular tachycardia that was induced in 40% of the patients is unclear. The induced arrhythmia appeared to differ from the spontaneous episode in rate as well as morphology of the QRS complexes. None of the induced episodes had the typical torsade de pointes configuration. It was difficult to compare the spontaneous ventricular tachycardia with that induced in the laboratory, especially when only one lead was available. Furthermore, three extrastimuli were required for the induction of the majority of the induced paroxysms. It has been recently reported that the induction of rapid nonsustained polymorphic ventricular tachycardia with three extrastimuli may be a nonspecific finding. 17 Inducibility or lack of inducibility did not appear to have clinical significance. While almost all patients showed spontaneous episodes of ventricular tachycardia or fibrillation, ventricular arrhythmias were induced in only 40%. Furthermore, none of the four patients who suffered cardiac arrest in the follow-up period had inducible ventricular tachycardia in the baseline study. Therefore, inducibility of arrhythmia does not appear to be of any clinical or prognostic significance, and the lack of inducibility does not identify a low-risk group. The poor correlation between spontaneous and inducible ventricular tachycardia may result from the fact that spontaneous ventricular tachycardia is related to transient surges in adrenergic discharge or some other undefined neural factors that were not present at the time of programmed ventricular stimulation. Syncope or cardiac arrest in patients with LQTS frequently occur in association with sudden in-creases in sympathetic discharge produced by conditions such as physical exertion or emotional stress.`S Recently Bonatti et al. 18 reported large differences in the duration of monophasic action potentials recorded from different areas of the right ventricle in 10 patients with prolonged QT intervals. However, the majority of patients had an acquired prolongation of the QT interval. The relationship of refractoriness of the myocardium to the duration of action potential is well established. 19 In the present study no significant difference was seen in the effective refractory periods of the ventricles measured at two or more sites. Thus, in our experience, wide differences in VERP were not a feature of congenital or idiopathic LQTS.
For patients with symptoms refractory to medical therapy with /3-blockers, LCTS has been reported to be a very effective mode of therapy. It has been recommended that the left stellate ganglion and the first three or four thoracic ganglia be ablated to ensure that the surgery is effective.6 7 However, four of our eight patients who underwent LCTS developed recurrent symptoms that included sudden cardiac arrest in two and syncope in two (table 5 ). The addition of 3- blockers to the therapeutic regimen also proved to be relatively disappointing. In one patient (patient I 1) the recurrent symptoms were probably related to an inadequate sympathectomy because only the left stellate ganglion was removed; this patient became asymptomatic after LCTS and long-term atrial pacing. The reasons for the recurrent symptoms in the other four patients are unclear. These patients were comparable to those previously reported with respect to their clinical manifestations and the extent of cardiac sympathectomy. The partial failure of LCTS in our patients may have been because of individual variability. The possibility exists that the disease was severe in some of our patients and that a more extensive sympathectomy with ablation of the first six thoracic ganglia would have been more effective. However, the superiority of the more extensive sympathectomy over that in which three to four thoracic ganglia are removed has never been objectively documented. QT response to incremental atrial pacing. In normal subjects rapid heart rates resulting from exercise, isoproterenol infusion, or atrial pacing are associated with a shortening of the QT interval.
However, in patients with LQTS both exercise and isoproterenol infusion have been reported to produce a paradoxical prolongation of the QT interval.8 1 ' These interventions have therefore been used as provocative tests in patients with LQTS and variability of the QT interval, especially in those who at times have normal QT intervals. In the present series three of the 15 patients at times had normal QT intervals.
In this study we evaluated the response of the QT interval to atrial pacing in control subjects and patients with LQTS. Our findings demonstrate that atrial pacing significantly shortens QT interval in both groups of patients, and the percent change in the QT shortening fails to distinguish patients with LQTS from control subjects. The normal responses of QT to atrial pacing in those with LQTS may be related to the absence of any concomitant increase in adrenergic activity when rapid heart rates are achieved.20 Thus, changes in the QT interval induced by atrial pacing failed to distinguish normal individuals from those with LQTS.
QT response to propranolol. /3-Blocker therapy has been reported to produce shortening or no change in the QT interval.i8 Recently Milne et al. 23 reported that intravenous propranolol produced a differential effect on the QT of patients with the familial vs the idiopathic form of the syndrome when heart rate was kept constant by atrial pacing. In that study two patients with familial syndrome showed QT shortening, whereas QT was unchanged in the other two, who had the idiopathic form of the syndrome. Our results failed to confirm this finding; intravenous propranolol did not significantly affect the QT interval measured at constant atrial-paced cycle lengths in either the familial or the idiopathic form of the syndrome. Our findings are comparable to the previously reported effects of shortterm /3-blockade on the QT interval of normal subjects.20-24Therefore, in both the normal subject and the patient with LQTS, propranolol given over the short term has no rate-independent effect on the QT interval. The effects of long-term /3-blockade on the QT interval remain to be determined. Clinical implications. There are several important clinical implications of this study. Programmed ventricular stimulation did not induce sustained ventricular tachyarrhythmias in any of the 15 patients with LQTS. Nonsustained polymorphic ventricular tachycardia, although inducible in about one-third of the patients, did not appear to be of any clinical or prognostic significance. Furthermore, the lack of inducibility of ventricular tachycardia or fibrillation did not identify a low-risk group. The QT response to fixedrate atrial pacing did not differentiate control subjects from patients with LQTS. Finally, short-term /3-blockade produced by intravenous propranolol had no rateindependent effect on the QT interval of patients with either the familial or idiopathic form of the syndrome. We therefore believe that electrophysiologic studies are of limited value in the symptomatic patient with LQTS.
